arrow
A

Anton Gietl

University of Zurich
H指数:26
被引数:2,529

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the link between intravoxel incoherent motion measured brain diffusivity during wakefulness and sleep macrostructure in the elderly

探索清醒与睡眠宏观结构期间测量的体素内不相干运动脑扩散性与老年人群之间的关系

2026-07-020
OAAI
Independent and interactive contributions of white matter hyperintensities and Alzheimer’s disease imaging and plasma biomarkers to cognitive decline in older adults without dementia

白质高信号和白质高信号与阿尔茨海默病影像及血浆生物标志物的独立和交互作用对无痴呆老年人认知衰退的贡献

2026-03-300
OAAI
International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative

神经认知障碍社会认知评估的国际共识:SIGNATURE倡议的框架定义与临床建议

2025-12-060
OAAI
Predicting cognitive decline with amyloid-PET, plasma p-tau217, Aβ42/40, and p-tau217/Aβ42 in a community-based cohort – relevance for clinical trial enrollment

使用Aβ-PET、血浆p-tau217、Aβ42/40和p-tau217/Aβ42预测认知衰退——对临床试验入组的意义

2025-10-210
OAAI
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland

Felbecker A, Rouaud O, Lathuilliere A. 等. 抗淀粉样蛋白单克隆抗体用于阿尔茨海默病治疗:瑞士跨学会关于其合理使用的建议. 神经退行性疾病, 2025; 14: 1–12.

2025-10-012
OAAI
Protective Effects of Socioeconomic Status and Lifestyle on Amyloid- and White Matter Hyperintensity-Related Longitudinal Brain Atrophy and Cognitive Decline

社会经济地位和生活方式对与淀粉样蛋白和白质高信号相关的纵向脑萎缩及认知衰退的保护作用

2025-08-090
OAAI
Altered T-cell reactivity in the early stages of Alzheimer's disease

阿尔茨海默病早期T细胞反应性改变

Brain
IF11.7
2025-05-050
OA